HIMS News

Hims & Hers Health, Inc. (NYSE:HIMS) SHAREHOLDER ALERT: Investors With Losses May Seek to Lead the Class Action in Hims & Hers Health, Inc. Securities Lawsuit - Contact Portnoy Law Firm

HIMS INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline - RGRD Law

Pomerantz LLP Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit – HIMS

Kaplan Fox Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors Seeking Recovery to Contact the Firm Before November 2, 2026

Deadline Alert: Hims & Hers Health, Inc. Investors Have Until November 2, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds Investors

Kaplan Fox Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors Who Suffered Losses to Seek a Leadership Role Before November 2, 2026

HIMS 1-WEEK DEADLINE ALERT: Hims & Hers Health Investors with Significant Losses Encouraged to Contact Hagens Berman Before Nov. 2, 2026 Deadline in Securities Class Action

HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law

HIMS Deadline in 7 Days: Hims & Hers Health, Inc. (NYSE: HIMS) Class Action Lawsuit Seeks Recovery for Investors; November 2, 2026 Deadline- Contact Kessler Topaz Meltzer & Check, LLP

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Unicycive Therapeutics, Inc. (UNCY), Hims & Hers Health, Inc. (HIMS), and Beta Bionics, Inc. (BBNX) Announced by Holzer & Holzer, LLC